2025 - Introduced
Minnesota S.F. 1946/H.F. 1806
  • Requires health insurers cover non-opioid treatments and prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids. Also requires health insurers to distribute non-opioid educational materials to in-network providers and enrollees and to publish resources on the health plan company's website.
State Regulated Commercial ParityProvider Education
Read Senate BillRead House Bill
2025 - Introduced
Minnesota S.F. 1947/H.F. 1807
  • Requires that in establishing and maintaining Minnesota's preferred drug list, health insurers must not disadvantage or discourage a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Senate BillRead House Bill
2025 - Introduced
Mississippi H.B.1389
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state Medicaid program.
Medicaid Parity
Read Bill
2026 - Introduced
Missouri H.B. 1680
  • Requires commercial plans to cover non-opioid medications for acute pain without disadvantaging them compared to opioids.
State Employee Health Plan Parity
Read House Bill
2026 - Introduced
Missouri H.B. 1966
  • Requires health insurance plans to cover non-opioid medications for acute pain without denying coverage, mandating prior opioid use, or charging higher cost-sharing compared to opioids.
State Employee Health Plan Parity
Read House Bill
2026 - Introduced
Missouri H.B. 2296
  • Requires Missouri health insurance plans to cover non-opioid medications for acute pain without denying coverage, mandating prior opioid use, or charging higher cost-sharing compared to opioids.
State Employee Health Plan Parity
Read House Bill
2026 - Introduced
Missouri H.B. 2372
  • Requires insurance to cover non-opioid medications for enrollees at elevated risk of opioid misuse without requiring prior opioid use, denying coverage in favor of opioids, or imposing higher cost-sharing.
State Employee Health Plan Parity
Read House Bill
2026 - Introduced
Missouri S.B. 1024
Limits initial opioid prescriptions for acute pain in Missouri to a seven-day supply, requires practitioners to discuss risks, alternatives, and dosing options with patients, and mandates documentation if a longer supply is medically necessary.
Medicaid ParityState Employee Health Plan Parity
Read Senate Bill
2026 - Introduced
Missouri S.B. 902/S.B. 1340/S.B. 1449/S.B. 841
  • Requires Missouri commercial plans to cover non-opioid medications for acute pain without denying coverage in favor of opioids, mandating prior opioid use, or imposing higher cost-sharing when prescribed.
State Employee Health Plan Parity
Read S.B. 902Read S.B. 1350Read S.B. 1449Read S.B. 841
2025 - Introduced
Missouri S.B.158/H.B. 804
  • For enrollees with an increased risk of opioid abuse, prohibits health insurers from: (1) denying coverage for non-opioid prescription drugs in favor of opioid drugs; (2) requiring an enrollee try an opioid prescription drug prior to approving the use of a non-opioid prescription drug; or (3) requiring a higher cost-sharing for non-opioid prescription drugs.
State Regulated Commercial Parity
Read Senate BillRead House Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B. 252
  •  Requires Medicaid and commercial plans to treat non-opioid medications equally to opioids, prohibits restrictions, higher cost-sharing, and allows prescribers to override coverage restrictions when appropriate.
  • Takes effect immediately upon FDA approval of a non-opioid drug and aims to improve access to non-opioid pain management.
Medicaid Parity
Read Bill